Login Register
English
0

Cart

$ 0

p35 Polyclonal Antibody

p35 Polyclonal Antibody

Views(5) Publications(1) Catalog no(ABP52111)
Datasheet Print Share Email Share
  • Specification
  • FAQ
  • Publications(1)
  • Comments(0)

Specification

Product name p35 Polyclonal Antibody
Immunogen Synthesized peptide derived from the N-terminal region of human p35 at AA range: 30-110
Host Rabbit
Reactivity Human,Mouse,Rat
Applications WB,IHC,IF,ELISA
Applications notes Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:20000;Not yet tested in other applications.
Clonality Polyclonal
Preparation method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative CDK5R1; CDK5R; NCK5A; Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1; TPKII regulatory subunit

Product Properties

Formulation Liquid solution
Concentration 1 mg/ml
Molecular weight 38kD
Storage buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage instructions Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Shipping Gel pack with blue ice.
Precautions The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Additional Information

Background Cyclin dependent kinase 5 regulatory subunit 1 encoded by CDK5R1 (p35) is a neuron-specific activator of cyclin-dependent kinase 5 (CDK5); the activation of CDK5 is required for proper development of the central nervous system. The p35 form of cyclin dependent kinase 5 regulatory subunit 1 is proteolytically cleaved by calpain, generating a p25 form. The cleavage of p35 into p25 results in relocalization of the protein from the cell periphery to nuclear and perinuclear regions. P25 deregulates CDK5 activity by prolonging its activation and changing its cellular location. The p25 form accumulates in the brain neurons of patients with Alzheimer's disease. This accumulation correlates with an increase in CDK5 kinase activity, and may lead to aberrantly phosphorylated forms of the microtubule-associated protein tau, which contributes to Alzheimer's disease.
Gene ID 8851
Alternative CDK5R1; CDK5R; NCK5A; Cyclin-dependent kinase 5 activator 1; CDK5 activator 1; Cyclin-dependent kinase 5 regulatory subunit 1; TPKII regulatory subunit
Others p35 Polyclonal Antibody detects endogenous levels of p35 protein.
Accession Q15078
Observed Band(KD) 38

Image & description

Fig.1. Western Blot analysis of various cells using p35 Polyclonal Antibody diluted at 1:1000.

Fig.1. Western Blot analysis of various cells using p35 Polyclonal Antibody diluted at 1:1000.

Fig.2. Western Blot analysis of hela cells using p35 Polyclonal Antibody diluted at 1:1000.

Fig.2. Western Blot analysis of hela cells using p35 Polyclonal Antibody diluted at 1:1000.

This product has been cited in1publications

Reviews

There are no reviews yet.

Be the first to review “p35 Polyclonal Antibody”